An 11 year old boy with cystic fibrosis suffered a stroke, producing right sided weakness. Four years previously a totally implantable venous access device (Port-aCath) had been inserted. Magnetic resonance angiography revealed a filling defect in the left middle cerebral artery. Transoesophageal echocardiography demonstrated a thrombus attached to the tip of the Port-a-Cath and also the presence of a patent foramen ovale. After an initial period of anticoagulation the defect was closed using a septal occlusion device introduced via a cardiac catheter. The boy's neurological signs completely resolved and he remains free from further thromboembolic episodes. Whilst pulmonary embolism has been described before in relation to a totally implantable venous access device, this is believed to be the first description of a paradoxical embolism in relation to such a device.
An 11 year old boy with cystic fibrosis was admitted to hospital with sudden onset of confusion and slurred speech. On examination he was found to have a right-sided hemiparesis, expressive and receptive dysphasia. He had originally presented at the age of two days with a meconium ileus and was subsequently found to be homozygous for the F508 deletion. A sweat test performed at the age of four months confirmed the diagnosis of cystic fibrosis. Since the age of four he had required many hospital admissions for intravenous antibiotic therapy. In February 1992 a Port-a-Cath was inserted via the right internal jugular vein and secured to the anterior chest wall. His lung function was considerably compromised with a forced expiratory volume in one second (FEV 1 ) of 0.63 l (35% predicted) and a forced vital capacity (FVC) of 0.98 l (49% predicted).
A computed tomographic (CT) brain scan performed on the day after admission revealed a poorly defined area of low attenuation in the left temporoparietal region which was suggestive of ischaemia in the territory of the left middle cerebral artery. Magnetic resonance angiography confirmed recent ischaemia in this region with evidence of an embolus in the left middle cerebral artery. A transthoracic echocardiogram was performed which showed an unusual Ebstein's-like deformity of the tricuspid valve; the proximal part of the septal leaflet of the tricuspid valve was displaced apically with a point of attachment in the mid body of the right ventricle. Mild tricuspid regurgitation was also seen but no other abnormalities were apparent.
Ebstein's anomaly is associated with abnormal intra-atrial connections and therefore a transoesophageal echocardiogram was arranged. This was performed under general anaesthesia and demonstrated a small patent foramen ovale, the anterior border abutting the posterior aspect of the ascending aorta. The Port-a-Cath was seen in the right atrium and was noted to impinge against the tricuspid valve during the cardiac cycle. In addition, a large thrombus was seen attached to the tip of the Port-a-Cath in the right atrium.
Despite using intravenous contrast, no right to left shunt was demonstrable during the procedure. Techniques to enhance any right to left shunt such as coughing and the Valsalva manoeuvre were not possible because of the general anaesthetic.
The patient was anticoagulated with warfarin and started on an anti-platelet dose of aspirin. One month later the defect was closed using a 9 mm atrial septal occlusion device introduced via a cardiac catheter (fig 1) . By this time the neurological signs had completely resolved and aspirin was discontinued after three months. There have been no further episodes of thromboembolism. Thromboembolism has been described as a complication relating to the use of totally implantable venous access devices 2 but we believe this is the first time that a paradoxical embolism has been described in relation to the use of such a device.
Paradoxical embolism can only be considered proven if a venous thrombus is detected lodged in an intracardiac septal defect. This degree of certainty is extremely rare, but has been demonstrated during life using both transthoracic and transoesophageal echocardiography. 3 4 More often we can assume paradoxical embolism if "Johnson's triad" exists-that is, (1) venous thrombosis with or without pulmonary embolism, (2) an intracardiac defect with right to left shunting, and (3) arterial embolism without a corresponding source in the left heart or proximal arterial tree. 5 The reported incidence of a patent foramen ovale varies from 5% to 30%. In younger adults with ischaemic stroke, where the cause may be undefined in up to 35% of cases, the incidence of a patent foramen ovale is significantly higher at around 40%. 6 This suggests that paradoxical embolism occurs more frequently than was previously thought.
Paradoxical embolism is more likely in the setting of a chronic cough, as in cystic fibrosis.
Coughing and the Valsalva manoeuvre are used during contrast echocardiography to promote right to left shunting across a patent foramen ovale, and indeed coughing is felt to be the most eVective manoeuvre to demonstrate such shunting. 7 Any child with an unexplained stroke requires a careful cardiological examination, particularly if there are risk factors such as an indwelling venous access device and a chronic cough. If transthoracic echocardiography shows no abnormality then more invasive investigations should be considered such as transoesophageal echocardiography.
Transcatheter techniques such as that used in our patient can oVer significant advantages over open surgery in patients with cystic fibrosis. Postoperative recovery is quicker with less interruption to physiotherapy, and the avoidance of sternotomy may have important implications for any proposed heart-lung transplantation. 
LETTERS TO THE EDITOR

Surgery and respiratory muscles
In their review of the eVects of surgery on the respiratory muscles Siafakas and co-workers have cited my work incorrectly on two occasions. 1 We reported a study of respiratory mechanics after abdominal surgery with measurements of the pressure-volume characteristics of the rib cage and abdomen. 2 This report has been cited to support statements on the eVects of surgery on gas exchange eYciency of the lung and of general anaesthesia on the thorax. On neither occasion is this citation appropriate. We found evidence that the abdominal muscles were active in patients after abdominal surgery, that this activity was variable, and that it could possibly explain the patterns of movement otherwise considered to represent "diaphragmatic dysfunction". These observations, along with a short review of the published work on the subject, formed an editorial 3 in which I argued that the concept of diaphragmatic dysfunction was outmoded. This work has been cited in support of the eVects of laparoscopic chole cystectomy, which is incorrect. Indeed, there is remarkably little direct evidence that the intercostal inspiratory muscles become more active in the patient after surgery. There is also little direct evidence in humans that the diaphragm is the respiratory muscle most aVected by surgery.
Many of the changes in the shape of the thorax caused by the induction of anaesthesia can be attributed to a loss of skeletal muscle tone, with a change in the shape of the vertebral column. If this is prevented, then the changes in thoracic dimensions during induction of anaesthesia are small, variable, and do not require the hypothesis of major movements of intravascular volume as indicated in fig 1 of AUTHORS' REPLY We wish to thank Dr Drummond for pointing out the incorrect citation of his work in our recent review. 1 We apologise for this, especially for quoting his editorial 2 for the eVects of laparoscopic cholecystectomy on the respiratory muscles. However, we have extensively discussed the semantics of the term "diaphragmatic dysfunction" in the methodological part of our review, sharing some of Dr Drummond's views. 2 Furthermore, we have cited the work of Dr Drummond and colleagues in the general discussion of the function of respiratory muscles during surgery, arguing that respiratory muscle dysfunction, in the general sense of the term, could influence functional residual capacity. We believe that this is in agreement with Dr Drummond's findings that upper abdominal surgery alters the relative activity of respiratory muscles (including the abdominal muscles) leading to changes in the rib cage abdominal configuration (fig 1, Nimmo and Drummond   3 ). Similarly, we have cited his work to support the argument that general anaesthesia causes volume displacement between the thoracic and abdominal cavities. Dr Drummond argues that this could be due to the loss of skeletal muscle tone. We have no objection to this since the respiratory muscles are skeletal muscles too. Furthermore, the changes seen in the pattern of breathing after upper abdominal surgery and the relative contributions of the rib cage and abdomen during quiet breathing have been attributed by most investigators to dysfunction of the diaphragm.
4-6 Dr Drummond's experiments oVer another explanation, pointing out the role of the abdominal muscles (the major expiratory muscles). Our own experiments have shown that upper abdominal surgery impairs the global strength of the inspiratory and expiratory muscles to produce maximum pressure. 7 8 It is well known that the major contributor to the maximum inspiratory pressure (MIP) is the pressure produced by the diaphragm. Thus, it is logical to suggest that, if MIP is grossly reduced after surgery, this is primarily due to diaphragmatic dysfunction. We believe that the above diVerences may be due to the diVerent experimental conditions (quiet breathing versus maximum static pressures). 
Postoperative air leaks
The study by Waller et al 1 did not attempt to compare the clinical benefit, cost effectiveness, or relative convenience of the two alternative chest drainage systems-a flutter valve drainage bag or the conventional underwater seal. Instead it claims that the flutter valve oVers "a physiologically more eVective" alternative to the underwater system. However, a pneumothorax is a pathological rather than a physiological condition in which it is imperative to remove air from the pleural cavity. In this situation the pleural pressures will be higher than in the normal physiological state and, indeed, air will only exit the pleural cavity via a chest drain when the pleural pressure exceeds atmospheric pressure. Any drainage system for a pneumothorax that renders the pleural pressure more negative (relative to the atmospheric pressure) will therefore reduce the exit of air, other than by more forcible expiration, and reduce its eVectiveness.
A further theoretical but serious consideration is that of re-expansion pulmonary oedema (REPE). This has been associated with excessively negative pleural pressures after removal of air 2 or fluid 3 from the pleural space.
The study concludes that an ideal postoperative drainage system will "allow the maintenance of a negative intrapleural pressure, even in the presence of an air leak". In our view a negative pleural pressure in this situation would only serve to encourage the egress of more air from the damaged lung surface into the pleural cavity, thus worsening the situation.
Whilst accepting that the postoperative situation may diVer somewhat from that which pertains in a spontaneous pneumothorax because of the presence of fluid/blood in the pleural cavity, we would expect the same physiological principles to apply, especially in the presence of an air leak. There is a risk that the conclusions from this paper might be extrapolated into general respiratory practice and the scenario of spontaneous pneumothorax. For all of the above reasons we would urge caution before abandoning the standard and well tried technique of drainage of the pleural cavity (underwater seal) in favour of the suggested alternative, at least before data from larger, controlled clinical trials become available. AUTHORS' REPLY We thank Dr Henry and colleagues for their comments regarding our study. We must first emphasise that we were not intending to make any conclusions regarding the relative clinical or financial benefits of either drainage system, and that we were specifically addressing the situation of postoperative air leaks. We have shown that, at resting tidal volume, flutter valve drainage bags maintain a more negative (but not excessively negative) intrapleural pressure than underwater seal systems and therefore are more likely to restore the normal physiology of the pleural space. The aim of chest drainage in this situation is to restore and maintain the negative intrathoracic pressure necessary for lung re-expansion which will allow reactivation of the surface forces promoting visceral and parietal pleural apposition.
M HENRY
1 This is dependent on removing excess gas or fluid from the pleural space. We cannot therefore agree with the assertion of Dr Henry and colleagues that achieving negative intrapleural pressure will reduce the exit of air (by which we assume they mean will reduce lung expansion). While it has been shown that excessive pleural suction in the presence of a high flow bronchopleural fistula may perpetuate air leakage, 2 Henry et al are ill advised to extrapolate this principle to the more common clinical scenario of a smaller volume air leak.
Re-expansion pulmonary oedema is a recognised but uncommon complication of chest drainage which reflects the rapidity of lung re-expansion. 3 This is rare in prolonged chest drainage for persistent air leakage and the concerns of Dr Henry and colleagues cannot be justified.
We welcome the opportunity to discuss this common but seldom debated area of respiratory practice. The standard and well tried method of underwater seal drainage is a source of many misunderstandings and complications. 4 The Heimlich flutter valve, whose physics we have studied, has been shown to be clinically eVective by Graham et al 5 and others and further data from a randomised clinical trial in prolonged air leakage will soon be forthcoming. 
Rare diseases
We welcome the series of articles on rare pulmonary disorders which started in the March 1999 issue of Thorax. In the introduction to the series Tattersfield and Du Bois 1 describe the frustrations felt by patients unable to obtain information about their rare pulmonary condition from clinicians with little or no experience of that disorder. The isolation of such patients is emphasised when they are unable to share their experiences with others diagnosed with the same disorder. Whilst we appreciate that this is true for many patients, we would draw attention to the massive range of information on rare pulmonary disorders available to both patients and doctors via the Internet. There are over three million UK subscribers to the Internet currently and, with the advent of digital television, this number will rise exponentially over the next few years. The problem then facing the patient (and clinician) is too much information. For example, lymphangioleiomyomatosis, the subject of the first article in the series, has over 500 Internet sites accessible worldwide to patients. We hope to provide assistance to patients who may lack confidence in knowing where to turn for information relevant to their needs.
The North East Thames Training Programme for Specialist Registrars has run an Internet based educational programme for medical trainees for over two years. Using this experience, trainees and trainers are now opening a website for patients with rare pulmonary disorders. The group is evaluating existing websites for validity of medical information and the relevance of presentation and content for patient rather than medical needs. It is hoped that the resulting reference site will index all available Internet information and allow patients to access information that is both reliable and relevant. To achieve this goal we are working with the help of patient support groups based with the British Lung Foundation, Organising Medical Networked Information (OMNI), and the Oxford University and British Library health care information team. This is an enormous project which we feel will have increasing importance with time. We have already received oVers of help from registrars in Wales, Scotland, and Australia. The North East Thames registrars welcome oVers of co-operation from other similar groups. AUTHORS' REPLY We agree with Dr Roberts that the Internet raises special issues for patients with rare diseases and that the problem is often too much information rather than too little. With respect to lymphangioleiomyomatosis (LAM), our approach in Nottingham has been to produce a four page fact sheet for patients which we have given to patients in the LAM Trust and to some of the doctors looking after the patients. The fact sheet was piloted amongst a few patients with LAM and modified in the light of the feedback we received. Several patients have obtained the fact sheet from the LAM Foundation in the USA which goes into slightly more detail than our document, particularly with respect to prognosis; as might be expected, some patients appreciate the further information whilst others do not. Whether specialist registrar trainees should be deciding what patients with a rare disease should be encouraged to read is more debatable since some will never have met a patient with the disease in question. It seems more appropriate to us for fact sheets and information to be provided by people with some knowledge and expertise of managing patients with the particular disease, in conjunction with the patients themselves. The British Thoracic Society is planning to develop an orphan disease register and to encourage research into rare disorders. One of their remits will be to consider what information is required and how it should be presented and piloted. 
C M ROBERTS
